Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CRISPR
CRISPR
What to know about the U.K.’s approval of the first CRISPR treatment for diseases
What to know about the U.K.’s approval of the first CRISPR treatment for diseases
Nature
UK
CRISPR
gene editing
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
Flag link:
Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK
Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK
BioSpace
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
UK
Casgevy
beta thalassemia
Flag link:
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
BioSpace
CRISPR
gene therapy
cell therapy
sickle cell disease
exa-cel
Vertex Pharmaceuticals
CRISPR Therapeutics
Flag link:
As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations
As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations
Fierce Pharma
Vertex Pharmaceuticals
CRISPR
gene editing
FDA
exa-cel
Flag link:
Tracking the FDA’s meeting on Vertex, CRISPR’s sickle cell therapy
Tracking the FDA’s meeting on Vertex, CRISPR’s sickle cell therapy
BioPharma Dive
FDA
Vertex Pharmaceuticals
CRISPR
sickle cell disease
exa-cel
Flag link:
FDA Flags Off-Target Effects of Vertex, CRISPR’s Sickle Cell Therapy Ahead of Adcomm
FDA Flags Off-Target Effects of Vertex, CRISPR’s Sickle Cell Therapy Ahead of Adcomm
BioSpace
Vertex Pharmaceuticals
exa-cel
CRISPR
sickle cell disease
FDA
Flag link:
Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing
Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing
Investors Business Daily
Intellia
CRISPR
gene editing
transthyretin amyloidosis with cardiomyopathy
Flag link:
VedaBio Launches with $40+ Million Toward a CRISPR Molecular Detection Platform
VedaBio Launches with $40+ Million Toward a CRISPR Molecular Detection Platform
Genetic Engineering News
VedaBio
CRISPR
molecular detection
Flag link:
A decade later, biotech’s CRISPR revolution is still going strong
A decade later, biotech’s CRISPR revolution is still going strong
BioPharma Dive
CRISPR
gene editing
biotech
Flag link:
AbbVie Terminates Collaboration and License Agreement with Caribou Biosciences
AbbVie Terminates Collaboration and License Agreement with Caribou Biosciences
Best Stocks
AbbVie
Caribou Biosciences
CRISPR
Flag link:
Why Shares of Tango Therapeutics Climbed This Week
Why Shares of Tango Therapeutics Climbed This Week
Motley Fool
Tango Therapeutics
CRISPR
gene editing
clinical trials
Flag link:
First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results
First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results
Clinical Trials Arena
Vertex Pharmaceuticals
exa-cel
CRISPR
beta thalassemia
Flag link:
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions
Forbes
Scribe Therapeutics
CRISPR
gene editing
Benjamin Oakes
Flag link:
CRISPR on the Cusp: The Promise and the Pain Points
CRISPR on the Cusp: The Promise and the Pain Points
BioSpace
Intellia Therapeutics
HAE
NTLA-2002
CRISPR
Flag link:
Patients attack-free a year after receiving Intellia's hereditary angioedema CRISPR med
Patients attack-free a year after receiving Intellia's hereditary angioedema CRISPR med
Fierce Biotech
Intellia Therapeutics
HAE
hereditary angiodema
CRISPR
NTLA-2002
Flag link:
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Fierce Biotech
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
FDA
sickle cell disease
beta thalassemia
Flag link:
BIO: Caribou tries to 'go where the puck is going' by taking on cell therapy rivals on home ice
BIO: Caribou tries to 'go where the puck is going' by taking on cell therapy rivals on home ice
Fierce Biotech
BIO 2023
Caribou Biosciences
lymphoma
CRISPR
cell therapy
Flag link:
Scribe's CRISPR tech Prevails in new $1.5B biobucks deal with Lilly unit
Scribe's CRISPR tech Prevails in new $1.5B biobucks deal with Lilly unit
Fierce Biotech
Scribe Therapeutics
Eli Lilly
CRISPR
Prevail Therapeutics
gene therapy
biobucks
Jennifer Doudna
Flag link:
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
BioPharma Dive
Function Oncology
CRISPR
diagnostics
funding
cancer
Flag link:
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
Medtech Dive
Function Oncology
funding
CRISPR
diagnostics
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »